These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29428146)

  • 1. Management of Perioperative Anticoagulation for Device Implantation.
    Stewart MH; Morin DP
    Card Electrophysiol Clin; 2018 Mar; 10(1):99-109. PubMed ID: 29428146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of safety and efficacy of uninterrupted warfarin compared to heparin-based bridging therapy during implantation of cardiac rhythm devices.
    Ghanbari H; Phard WS; Al-Ameri H; Latchamsetty R; Jongnarngsin K; Crawford T; Good E; Chugh A; Oral H; Bogun F; Morady F; Pelosi F
    Am J Cardiol; 2012 Nov; 110(10):1482-8. PubMed ID: 22906894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative management of oral anticoagulation in patients undergoing implantation of subcutaneous implantable cardioverter-defibrillator.
    Afzal MR; Mehta D; Evenson C; Pinkhas D; Badin A; Patel D; Essandoh MK; Godara H; Tyler J; Houmsse M; Liu Z; Kalbfleisch SJ; Hummel JD; Augostini R; Weiss R; Daoud EG; Okabe T
    Heart Rhythm; 2018 Apr; 15(4):520-523. PubMed ID: 29146276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative anticoagulation management in patients on chronic oral anticoagulant therapy undergoing cardiac devices implantation: a meta-analysis.
    Du L; Zhang Y; Wang W; Hou Y
    Pacing Clin Electrophysiol; 2014 Nov; 37(11):1573-86. PubMed ID: 25234639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pacemaker or defibrillator surgery without interruption of anticoagulation.
    Birnie DH; Healey JS; Wells GA; Verma A; Tang AS; Krahn AD; Simpson CS; Ayala-Paredes F; Coutu B; Leiria TL; Essebag V;
    N Engl J Med; 2013 May; 368(22):2084-93. PubMed ID: 23659733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perioperative anticoagulation in patients having implantation of a cardiac pacemaker or defibrillator: a systematic review and practical management guide.
    Jamula E; Douketis JD; Schulman S
    J Thromb Haemost; 2008 Oct; 6(10):1615-21. PubMed ID: 18638011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managing anticoagulation in patients receiving implantable cardiac devices.
    Chousou PA; Pugh PJ
    Future Cardiol; 2018 Mar; 14(2):151-164. PubMed ID: 29226707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perioperative management of antithrombotic therapy in patients receiving cardiovascular implantable electronic devices: a network meta-analysis.
    He H; Ke BB; Li Y; Han FS; Li X; Zeng YJ
    J Interv Card Electrophysiol; 2017 Oct; 50(1):65-83. PubMed ID: 28842832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuation of warfarin during pacemaker or implantable cardioverter-defibrillator implantation: a randomized clinical trial.
    Cheng A; Nazarian S; Brinker JA; Tompkins C; Spragg DD; Leng CT; Halperin H; Tandri H; Sinha SK; Marine JE; Calkins H; Tomaselli GF; Berger RD; Henrikson CA
    Heart Rhythm; 2011 Apr; 8(4):536-40. PubMed ID: 21147261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation.
    Ahmed I; Gertner E; Nelson WB; House CM; Dahiya R; Anderson CP; Benditt DG; Zhu DW
    Heart Rhythm; 2010 Jun; 7(6):745-9. PubMed ID: 20176137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced-dose warfarin or interrupted warfarin with heparin bridging for pacemaker or defibrillator implantation: a randomized trial.
    Schulman S; Healey JS; Douketis JD; Delaney J; Morillo CA
    Thromb Res; 2014 Oct; 134(4):814-8. PubMed ID: 25127655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost effectiveness of continued-warfarin versus heparin-bridging therapy during pacemaker and defibrillator surgery.
    Coyle D; Coyle K; Essebag V; Birnie DH; Ahmad K; Toal S; Sapp J; Healey JS; Verma A; Wells G; Krahn AD
    J Am Coll Cardiol; 2015 Mar; 65(9):957-9. PubMed ID: 25744016
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk of pocket hematoma in patients on chronic anticoagulation with warfarin undergoing electrophysiological device implantation: a comparison of different peri-operative management strategies.
    Proietti R; Porto I; Levi M; Leo A; Russo V; Kalfon E; Biondi-Zoccai G; Roux JF; Birnie DH; Essebag V
    Eur Rev Med Pharmacol Sci; 2015 Apr; 19(8):1461-79. PubMed ID: 25967723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implanting cardiac rhythm devices during uninterrupted warfarin therapy: a prospective, single center experience.
    Crosato M; Calzolari V; Franceschini Grisolia E; Daniotti A; Baldessin F; Mantovan R; Olivari Z
    J Cardiovasc Med (Hagerstown); 2015 Jul; 16(7):503-6. PubMed ID: 25022924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulation management in the perioperative phase of implantable cardioverter defibrillator implantation.
    Yokoshiki H; Mitsuyama H; Watanabe M; Mizukami K; Matsui Y; Tsutsui H
    Circ J; 2013; 77(8):2003-8. PubMed ID: 23676886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low-molecular weight heparin.
    Tischenko A; Gula LJ; Yee R; Klein GJ; Skanes AC; Krahn AD
    Am Heart J; 2009 Aug; 158(2):252-6. PubMed ID: 19619702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative management of antithrombotic treatment during implantation or revision of cardiac implantable electronic devices: the European Snapshot Survey on Procedural Routines for Electronic Device Implantation (ESS-PREDI).
    Deharo JC; Sciaraffia E; Leclercq C; Amara W; Doering M; Bongiorni MG; Chen J; Dagres N; Estner H; Larsen TB; Johansen JB; Potpara TS; Proclemer A; Pison L; Brunet C; Blomström-Lundqvist C;
    Europace; 2016 May; 18(5):778-84. PubMed ID: 27226497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Warfarin continuation vs interruption during procedures of cardiac rhythm devices: A Meta-analysis of randomized controlled trials.
    Sun H; Du B; Liu X; Yang S; Yang P
    J Pak Med Assoc; 2016 Apr; 66(4):458-65. PubMed ID: 27122276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular implantable electronic device implantation with uninterrupted dabigatran: comparison to uninterrupted warfarin.
    Jennings JM; Robichaux R; McElderry HT; Plumb VJ; Gunter A; Doppalapudi H; Osorio J; Yamada T; Kay GN
    J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1125-9. PubMed ID: 23889767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation.
    Tompkins C; Cheng A; Dalal D; Brinker JA; Leng CT; Marine JE; Nazarian S; Spragg DD; Sinha S; Halperin H; Tomaselli GF; Berger RD; Calkins H; Henrikson CA
    J Am Coll Cardiol; 2010 May; 55(21):2376-82. PubMed ID: 20488310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.